Demo Sign up Log In

Vertex Pharmaceuticals (VRTX)

Total Non-Current Assets

$14.88B

Quarterly · Period ending: Jun 30, 2026 · USD

VRTX Total Non-Current Assets

Latest reported$14.88Bperiod endingJun 30, 2026

Latest reported$14.88Bperiod endingJun 30, 2026

VRTX Quarterly Non-Current Assets ($4.60M → $14.88B)

Quarterly total non-current assets

High-resolution chart · PNG

VRTX total non-current assets history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Total Non-Current Assets — Quarterly (USD)
Period ending	Total Non-Current Assets (USD)
Jun 30, 2001	436,360,000
Mar 31, 2001	436,266,000
Dec 31, 2000	437,845,000
Sep 30, 2000	52,378,000
Jun 30, 2000	42,803,000
Mar 31, 2000	43,180,000
Dec 31, 1999	37,248,000
Sep 30, 1999	30,700,000
Jun 30, 1999	27,300,000
Mar 31, 1999	23,000,000
Dec 31, 1998	17,600,000
Sep 30, 1998	17,000,000
Jun 30, 1998	17,000,000
Mar 31, 1998	15,800,000
Dec 31, 1997	14,000,000
Sep 30, 1997	13,200,000
Jun 30, 1997	12,900,000
Mar 31, 1997	12,800,000
Dec 31, 1996	11,300,000
Sep 30, 1996	11,100,000
Jun 30, 1996	11,500,000
Mar 31, 1996	11,700,000
Dec 31, 1995	11,100,000
Sep 30, 1995	10,600,000
Jun 30, 1995	10,900,000
Mar 31, 1995	11,200,000
Dec 31, 1994	9,300,000
Sep 30, 1994	9,600,000
Jun 30, 1994	8,500,000
Mar 31, 1994	8,100,000
Dec 31, 1993	7,900,000
Sep 30, 1993	7,900,000
Jun 30, 1993	7,900,000
Mar 31, 1993	8,000,000
Dec 31, 1992	7,000,000
Sep 30, 1992	6,100,000
Jun 30, 1992	6,400,000
Mar 31, 1992	6,300,000
Dec 31, 1991	5,400,000
Sep 30, 1991	5,000,000
Jun 30, 1991	4,800,000
Dec 31, 1990	4,600,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.